Will Coronavirus herald a new era in vaccine innovation?

As this novel coronavirus continues to spread, and the number of people infected with COVID-19 keeps rising, the race is on to develop a vaccine. But the time it takes to carry out clinical trials, to ensure that a vaccine is both safe and effective, means this won’t happen overnight.

However, with at least 35 coronavirus vaccines now being developed, even compared to recent pandemics, we have new tools available that could help us reach that goal in record time.

Read more on the Gavi website here.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

Linked Community News: February 2024

This newsletter is available in English, Portuguese, Spanish, and Russian. Happy new year! We hope everyone is feeling revitalized following the holiday season. The Linked Network Facilitation Team has been hard at work preparing a series of exciting learning engagements and innovative initiatives to continue strengthening national immunisation programmes and we can’t wait to share … Read More

We’re Hiring: Request for Quotes for Technical Advisor to Support Subnational Learning Platform in Indonesia

Later this year, Linked will pilot a subnational peer-to-peer learning platform in Indonesia. The network’s approach for this subnational platform will be modeled by our global approach – engaging implementing partners such as WHO, UNICEF, and others to support the subnational government of Indonesia to adapt and implement learnings to achieve and sustain high and … Read More